개장 전 · Aug 17, 2026, EDT · 정보기술 · 매수

Whitehawk Therapeutics expands ADC pipeline with new option agreement for use of CPT113 linker-payload

[출처/시간] Briefing.com - 5:15 PM ET, 05/21/2026 Co announces it entered into a new option agreement with Hangzhou DAC for access to CPT113 for use in up to five additional ADC programs. Whitehawk's ADC platform leverages CPT113 as the core linker-payload technology, adding its own proprietary Carbon Bridge Cysteine Re-pairing (CBCR) bioconjugation process to support improved stability and therapeutic index.Per the terms of the option agreement, W

뉴스 | admin | May 21, 2026

Whitehawk Therapeutics expands ADC pipeline with new option agreement for use of CPT113 linker-payload

[출처/시간] Briefing.com - 5:15 PM ET, 05/21/2026

Co announces it entered into a new option agreement with Hangzhou DAC for access to CPT113 for use in up to five additional ADC programs. Whitehawk's ADC platform leverages CPT113 as the core linker-payload technology, adding its own proprietary Carbon Bridge Cysteine Re-pairing (CBCR) bioconjugation process to support improved stability and therapeutic index.Per the terms of the option agreement, Whitehawk will select targets and source antibodies, while retaining global rights and full program control for the new ADC programs. Whitehawk anticipates submitting Investigational New Drug (IND) applications for multiple new programs over the next 12-24 months.

Related Tags

SCHW_NEWS

3 Comments

김지나 Aug 15, 2026 at 3:49 am ↩

리포트 잘 봤습니다. 경쟁사 비교 차트가 한눈에 들어와서 좋네요. 다음 분기 가이던스가 어떻게 나올지 궁금합니다.
장창국 Aug 16, 2026 at 3:49 am ↩

같은 섹터의 ETF 흐름도 함께 보면 더 좋을 것 같습니다.
KRinus Aug 17, 2026 at 12:49 am ↩

의견 감사합니다. 곧 섹터 ETF 비교 차트를 별도 임베드로 추가할 예정입니다.

Related Tags

3 Comments

Leave a Comment

Related Posts